Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Fructose1035 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A09859 | 31589122 | Curr Drug Targets | Natural Aldose Reductase Inhibitor: A Potential Therapeutic Agent for Non-alcoholic Fatty Liver Disease. | 2020 | Details |
A09876 | 31578240 | Sci Transl Med | Controlled-release mitochondrial protonophore (CRMP) reverses dyslipidemia and hepatic steatosis in dysmetabolic nonhuman primates. | 2019 | Details |
A09918 | 31560861 | Can J Physiol Pharmacol | β-Sitosterol mitigates the development of high-fructose diet-induced nonalcoholic fatty liver disease in growing male Sprague-Dawley rats. | 2019 | Details |
A09924 | 31558860 | World J Gastroenterol | Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease. | 2019 | Details |
A09939 | 31553663 | Am J Physiol Regul Integr Comp Physiol | Sex modifies the consequences of extended fructose consumption on liver health, motor function, and physiological damage in rats. | 2019 | Details |
A09952 | 31545283 | Biomed Pharmacother | Gypenosides improve the intestinal microbiota of non-alcoholic fatty liver in mice and alleviate its progression. | 2019 | Details |
A09956 | 31543682 | World J Gastroenterol | Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source. | 2019 | Details |
A10020 | 31522189 | Am J Case Rep | Sugar and the Mosaic of Autoimmunity. | 2019 | Details |
A10049 | 31514051 | Redox Biol | Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function. | 2019 | Details |
A10054 | 31510077 | Nutrients | A Low Iron Diet Protects from Steatohepatitis in a Mouse Model. | 2019 | Details |
A10066 | 31504822 | Nutr Rev | Role of fruit juice in achieving the 5-a-day recommendation for fruit and vegetable intake. | 2019 | Details |
A10105 | 31482785 | Am J Trop Med Hyg | Opisthorchis viverrini Infection Augments the Severity of Nonalcoholic Fatty Liver Disease in High-Fat/High-Fructose Diet-Fed Hamsters. | 2019 | Details |
A10132 | 31473320 | Metab Eng | Determining contributions of exogenous glucose and fructose to de novo fatty acid and glycerol synthesis in liver and adipose tissue. | 2019 | Details |
A10171 | 31455870 | Int J Obes (Lond) | Specific diacylglycerols generated by hepatic lipogenesis stimulate the oncogenic androgen receptor activity in male hepatocytes. | 2019 | Details |
A10205 | 31433301 | J Hepatol | Integrin β1-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH. | 2019 | Details |
A10240 | 31415794 | Mol Cell Endocrinol | Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH). | 2019 | Details |
A10243 | 31414497 | J Sci Food Agric | Quercetin administration post-weaning attenuates high-fructose, high-cholesterol diet-induced hepatic steatosis in growing, female, Sprague Dawley rat pups. | 2019 | Details |
A10341 | 31383290 | Tissue Cell | Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice. | 2019 | Details |
A10367 | 31372694 | Naunyn Schmiedebergs Arch Pharmacol | Chrysin ameliorates nonalcoholic fatty liver disease in rats. | 2019 | Details |
A10426 | 31341444 | Integr Med (Encinitas) | Non-Alcoholic Fatty Liver Disease, an Overview. | 2019 | Details |
A10465 | 31325638 | Biochim Biophys Acta Mol Cell Biol Lipids | Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH. | 2019 | Details |
A10488 | 31315223 | Nutrients | Evidence for Toxic Advanced Glycation End-Products Generated in the Normal Rat Liver. | 2019 | Details |
A10515 | 31307427 | BMC Gastroenterol | A new method to induce nonalcoholic steatohepatitis (NASH) in mice. | 2019 | Details |
A10523 | 31301418 | Life Sci | (5R)-5-hydroxytriptolide ameliorates liver lipid accumulation by suppressing lipid synthesis and promoting lipid oxidation in mice. | 2019 | Details |
A10533 | 31299062 | PLoS One | AEBP1 expression increases with severity of fibrosis in NASH and is regulated by glucose, palmitate, and miR-372-3p. | 2019 | Details |
A10744 | 31213868 | Diabetes Metab Syndr Obes | The negative and detrimental effects of high fructose on the liver, with special reference to metabolic disorders. | 2019 | Details |
A10767 | 31203627 | J Agric Food Chem | Polyphenol-Rich Loquat Fruit Extract Prevents Fructose-Induced Nonalcoholic Fatty Liver Disease by Modulating Glycometabolism, Lipometabolism, Oxidative Stress, Inflammation, Intestinal Barrier, and Gut Microbiota in Mice. | 2019 | Details |
A10823 | 31173180 | Int J Mol Med | Excess fructose and fatty acids trigger a model of non‑alcoholic fatty liver disease progression in vitro: Protective effect of the flavonoid silybin. | 2019 | Details |
A10833 | 31168511 | Hepatol Commun | Lipocalin-2 Protects Against Diet-Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes. | 2019 | Details |
A10865 | 31151002 | J Mech Behav Biomed Mater | Biomechanics of cultured hepatic cells during different steatogenic hits. | 2019 | Details |
A10895 | 31136656 | Am J Clin Nutr | Different acute effects of fructose and glucose administration on hepatic fat content. | 2019 | Details |
A10912 | 31128886 | J Pediatr | The Role of Genetic Predisposition, Programing During Fetal Life, Family Conditions, and Post-natal Diet in the Development of Pediatric Fatty Liver Disease. | 2019 | Details |
A10926 | 31119399 | Eur J Nutr | Non-nutritive sweeteners and their association with the metabolic syndrome and non-alcoholic fatty liver disease: a review of the literature. | 2019 | Details |
A10927 | 31119300 | Cell Mol Life Sci | Persistent changes in liver methylation and microbiome composition following reversal of diet-induced non-alcoholic-fatty liver disease. | 2019 | Details |
A10928 | 31117231 | Nutrients | Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation. | 2019 | Details |
A10929 | 31116779 | PLoS One | A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE. | 2019 | Details |
A10930 | 31115630 | Appl Microbiol Biotechnol | Lactobacillus plantarum NA136 improves the non-alcoholic fatty liver disease by modulating the AMPK/Nrf2 pathway. | 2019 | Details |
A11010 | 31082799 | J Endocrinol | Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis. | 2019 | Details |
A11017 | 31081165 | Hepatology | Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice. | 2019 | Details |
A11024 | 31078624 | Gastroenterology | Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis. | 2019 | Details |
A11031 | 31076985 | Dig Dis Sci | Vitamin E Ameliorates Lipid Metabolism in Mice with Nonalcoholic Fatty Liver Disease via Nrf2/CES1 Signaling Pathway. | 2019 | Details |
A11105 | 31040374 | Sci Rep | Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine. | 2019 | Details |
A11148 | 31023717 | Biol Open | Longitudinal characterization of diet-induced genetic murine models of non-alcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients. | 2019 | Details |
A11190 | 31005808 | Phytomedicine | Amelioration of nonalcoholic fatty liver disease by swertiamarin in fructose-fed mice. | 2018 | Details |
A11192 | 31004828 | Cell Mol Gastroenterol Hepatol | Metabolic Targets in Nonalcoholic Fatty Liver Disease. | 2019 | Details |
A11195 | 31004566 | Biochem Pharmacol | Telmisartan and/or chlorogenic acid attenuates fructose-induced non-alcoholic fatty liver disease in rats: Implications of cross-talk between angiotensin, the sphingosine kinase/sphingoine-1-phosphate pathway, and TLR4 receptors. | 2019 | Details |
A11217 | 30991877 | Gut Microbes | High intake of dietary fructose in overweight/obese teenagers associated with depletion of Eubacterium and Streptococcus in gut microbiome. | 2019 | Details |
A11234 | 30981986 | J Nutr Biochem | Western diet consumption through early life induces microvesicular hepatic steatosis in association with an altered metabolome in low birth weight Guinea pigs. | 2019 | Details |
A11280 | 30959577 | Hepatology | Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol-Inducible Cytochrome P450-2E1-Mediated Oxidative and Nitrative Stress. | 2019 | Details |
A11311 | 30944821 | J Clin Transl Hepatol | Fatty Liver Disease and Gut Microbiota: A Comprehensive Update. | 2018 | Details |
A11312 | 30943987 | J Transl Med | Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes. | 2019 | Details |
A11348 | 30927921 | Lipids Health Dis | The severity of rat liver injury by fructose and high fat depends on the degree of respiratory dysfunction and oxidative stress induced in mitochondria. | 2019 | Details |
A11357 | 30924429 | Proc Nutr Soc | From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis. | 2019 | Details |
A11392 | 30915409 | Clin Exp Hepatol | Allopurinol potentiates the hepatoprotective effect of metformin and vitamin E in fructose-induced fatty liver in rats. | 2019 | Details |
A11400 | 30912307 | Physiol Rep | The long-term protective effects of neonatal administration of curcumin against nonalcoholic steatohepatitis in high-fructose-fed adolescent rats. | 2019 | Details |
A11424 | 30901028 | J Clin Endocrinol Metab | Patients With Aldolase B Deficiency Are Characterized by Increased Intrahepatic Triglyceride Content. | 2019 | Details |
A11433 | 30896960 | Rev Esp Enferm Dig | Metabolic characterization of two different non-alcoholic fatty liver disease pre-clinical mouse models. | 2019 | Details |
A11463 | 30885145 | BMC Gastroenterol | The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose. | 2019 | Details |
A11467 | 30883738 | J Physiol | Challenging metabolic tissues with fructose: tissue-specific and sex-specific responses. | 2019 | Details |
A11478 | 30879098 | Eur J Nutr | Moderate consumption of fermented alcoholic beverages diminishes diet-induced non-alcoholic fatty liver disease through mechanisms involving hepatic adiponectin signaling in mice. | 2019 | Details |
A11521 | 30860882 | Am J Physiol Endocrinol Metab | Transgenerational impact of maternal obesogenic diet on offspring bile acid homeostasis and nonalcoholic fatty liver disease. | 2019 | Details |
A11556 | 30841536 | Int J Mol Sci | mTOR is a Key Protein Involved in the Metabolic Effects of Simple Sugars. | 2019 | Details |
A11575 | 30833214 | Clin Nutr | Non-alcoholic fatty liver in hereditary fructose intolerance. | 2019 | Details |
A11603 | 30823422 | Nutrients | Dietary Sources of Fructose and Its Association with Fatty Liver in Mexican Young Adults. | 2019 | Details |
A11617 | 30818824 | Nutrients | A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver Slices. | 2019 | Details |
A11627 | 30813302 | Nutrients | The Relevance of Toxic AGEs (TAGE) Cytotoxicity to NASH Pathogenesis: A Mini-Review. | 2019 | Details |
A11653 | 30803502 | Nutr Res | Fructose threshold for inducing organ damage in a rat model of nonalcoholic fatty liver disease. | 2018 | Details |
A11657 | 30802722 | Nutr Res | Treatment with myo-inositol attenuates binding of the carbohydrate-responsive element-binding protein to the ChREBP-β and FASN genes in rat nonalcoholic fatty liver induced by high-fructose diet. | 2019 | Details |
A11662 | 30798914 | Med Hypotheses | Fructose-associated hepatotoxicity indexed by the lactate dehydrogenase isoenzyme LDH-5. | 2019 | Details |
A11700 | 30787473 | Eur J Clin Nutr | The role of dietary sugars in health: molecular composition or just calories? | 2019 | Details |
A11701 | 30787418 | Sci Rep | Transcriptional regulation of Hepatic Stellate Cell activation in NASH. | 2019 | Details |
A11721 | 30777418 | Rev Med Inst Mex Seguro Soc | Molecular alterations induced by fructose and its impact on metabolic diseases | 2019 | Details |
A11759 | 30763486 | Vopr Pitan | [Effect of quercetin on morphological changes in nonalcoholic fatty liver disease in high fructose-fed rats]. | 2018 | Details |
A11816 | 30723896 | Lipids | Molecular Characterization of Microvesicular and Macrovesicular Steatosis Shows Widespread Differences in Metabolic Pathways. | 2019 | Details |
A11844 | 30710884 | Nutrition | No association between fruits or vegetables and non-alcoholic fatty liver disease in middle-aged men and women. | 2018 | Details |
A11876 | 30700946 | World J Gastroenterol | Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease. | 2019 | Details |
A11881 | 34267963 | Florence Nightingale Hemsire Derg | [Is There an Effect of Dietary Fructose on Development and Prognosis of Chronic Diseases?] | 2019 | Details |
A11918 | 30682547 | Nutrition | Raw orange intake is associated with higher prevalence of non-alcoholic fatty liver disease in an adult population. | 2018 | Details |
A12004 | 30651350 | J Biol Chem | Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats. | 2019 | Details |
A12055 | 30621142 | Nutrients | Effect of Wakame and Carob Pod Snacks on Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
A12057 | 30619993 | Hepatol Commun | Childhood Fructoholism and Fructoholic Liver Disease. | 2018 | Details |
A12076 | 30611993 | Biomed Pharmacother | Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress. | 2019 | Details |
A12092 | 30605883 | Redox Biol | Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function. | 2018 | Details |
A12117 | 32864300 | Curr Pharmacol Rep | Dietary Additives and Supplements Revisited: The Fewer, the Safer for Liver and Gut Health. | 2019 | Details |
A12195 | 30567368 | Int J Mol Sci | Effective Food Ingredients for Fatty Liver: Soy Protein β-Conglycinin and Fish Oil. | 2018 | Details |
A12224 | 30556038 | Hepatol Commun | Perinatal Nutritional Reprogramming of the Epigenome Promotes Subsequent Development of Nonalcoholic Steatohepatitis. | 2018 | Details |
A12271 | 30539788 | Cell Mol Gastroenterol Hepatol | Macrophage Raptor Deficiency-Induced Lysosome Dysfunction Exacerbates Nonalcoholic Steatohepatitis. | 2018 | Details |
A12321 | 30516003 | Physiol Rep | Exercise training suppresses scavenger receptor CD36 expression in kupffer cells of nonalcoholic steatohepatitis model mice. | 2018 | Details |
A12327 | 30515333 | Int J Hepatol | Relationship between Experimental Diet in Rats and Nonalcoholic Hepatic Disease: Review of Literature. | 2018 | Details |
A12359 | 30487357 | Exp Anim | AIM-deficient mouse fed a high-trans fat, high-cholesterol diet: a new animal model for nonalcoholic fatty liver disease. | 2018 | Details |
A12367 | 30483565 | JGH Open | Is non-alcoholic fatty liver disease a reflection of what we eat or simply how much we eat? | 2018 | Details |
A12404 | 30469339 | Nutrients | Copper-Fructose Interactions: A Novel Mechanism in the Pathogenesis of NAFLD. | 2018 | Details |
A12405 | 30469030 | Redox Biol | Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes. | 2018 | Details |
A12406 | 30468651 | Front Biosci (Landmark Ed) | Fructose at the crossroads of the metabolic syndrome and obesity epidemics. | 2019 | Details |
A12502 | 30417996 | Pak J Biol Sci | Comparative Study of Orange and its Main Bioactive Constituents as Remedy for Non-alcoholic Fatty Liver in Rats. | 2018 | Details |
A12570 | 30387131 | J Cell Physiol | Repression of TXNIP-NLRP3 axis restores intestinal barrier function via inhibition of myeloperoxidase activity and oxidative stress in nonalcoholic steatohepatitis. | 2018 | Details |
A12599 | 30368556 | Eur J Nutr | Differential capability of metabolic substrates to promote hepatocellular lipid accumulation. | 2018 | Details |
A12613 | 30363947 | Oxid Med Cell Longev | Treatment of NASH with Antioxidant Therapy: Beneficial Effect of Red Cabbage on Type 2 Diabetic Rats. | 2018 | Details |
A12649 | 30347674 | Nutrients | Effects of Unfiltered Coffee and Bioactive Coffee Compounds on the Development of Metabolic Syndrome Components in a High-Fat-/High-Fructose-Fed Rat Model. | 2018 | Details |
A12708 | 30318957 | Arch Physiol Biochem | High-intensity interval training (HIIT) alleviated NAFLD feature via miR-122 induction in liver of high-fat high-fructose diet induced diabetic rats. | 2018 | Details |